TOP2A and non-small cell lung carcinoma: Mechanistic studies by Wu et al. highlighted that TOP2A played a pivotal role in immunotherapy efficacy and the formation of vascular mimicry–like structures in non-small cell lung cancer, mediated by increased Wnt3a and PD-L1 expression [40].